Same Indication

Ipilimumab vs Topiramate

Ipilimumab vs Topiramate: Overview

This comparison examines the pharmacological differences between Ipilimumab and Topiramate.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Topiramate: Multiple mechanisms: Na+ channel block, GABA enhancement, glutamate inhibition.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Topiramate β€” 21 hours.

Chemical Properties

Molecular Formula: Topiramate β€” C12H21NO8S.

Molecular Weight: Topiramate β€” 339.3630 g/mol.

Type: Ipilimumab β€” Antibody; Topiramate β€” Small molecule.